The short answer
Medicare negotiated drug prices lower the maximum amount Medicare pays for select medications, but your pharmacy copay may not change. If your Part D plan uses a flat copay, your cost stays the same. You will only see immediate savings if your plan charges a percentage-based coinsurance.
Key takeaways
- The first 10 negotiated drug prices took effect in 2026.
- 15 more drugs will join the negotiated pricing list in 2027.
- Flat copays may not drop even if the drug's price does.
- Coinsurance costs will decrease based on the new lower prices.
- Lower total drug costs mean you reach your out-of-pocket cap slower.
- Out-of-pocket costs are capped at $2,100 in 2026 and $2,400 in 2027.
- Plans can still require prior authorization for negotiated medications.
In this article
- How Medicare Negotiated Drug Prices Work in 2026 and 2027
- The First 10 Selected Drugs with Negotiated Prices
- The 15 New Medications Joining the Program for 2027
- Why Your Pharmacy Copay Did Not Drop Overnight
- How the 2026 and 2027 Part D Deductibles Impact Negotiated Drugs
- Formulary Tiers and Maximum Fair Prices
- How the 2026 and 2027 Out-of-Pocket Caps Protect You
- What to Check in Your Annual Notice of Change
- How to Compare Formulary Costs on Medicare Plan Finder
- How to Compare Medicare Part D Rates on Genie Medicare
When you hear the news about Medicare negotiated drug prices, it is easy to assume that your pharmacy bills will automatically plummet. For years, Americans on Medicare have faced high out-of-pocket costs for essential medications. Now, with new rules taking effect in 2026 and 2027, the landscape of Medicare Part D is shifting significantly.
However, the way these new prices actually impact your wallet is much more complex than a simple discount. Depending on how your specific Medicare Part D or Medicare Advantage plan is structured, you might see massive savings, or you might see your pharmacy costs stay exactly the same. Please note: Genie Medicare is an independent website and is not affiliated with or endorsed by the U.S. government or the federal Medicare program.
In this comprehensive guide, we will walk you through exactly how Medicare negotiated drug prices work, which medications are affected, and the crucial difference between flat copays and coinsurance. We will also explore how the new out-of-pocket caps protect you, and why reaching those caps might take longer than it used to.
How Medicare Negotiated Drug Prices Work in 2026 and 2027
Historically, the federal government was legally prohibited from negotiating the prices of prescription drugs directly with pharmaceutical companies on behalf of Medicare beneficiaries. Instead, individual Part D plan providers negotiated their own deals, which often left seniors exposed to high, unpredictable costs at the pharmacy counter.
Recent legislative changes granted Medicare the power to negotiate prices directly for some of the most expensive and widely used medications. These new, lower prices are known as "Maximum Fair Prices." This is the absolute highest amount that a pharmaceutical company can charge Medicare for a selected drug.
The Financial Impact of the New Rules
The rollout of these negotiated prices is projected to have a massive financial impact. According to official projections, the 2026 negotiated prices are expected to save Medicare beneficiaries $1.5 billion annually in out-of-pocket costs. Furthermore, the new pricing structure is projected to save the Medicare program itself an estimated $6 billion.
These savings are achieved by forcing manufacturers to lower the list price of their drugs. However, the Maximum Fair Price is the price negotiated between Medicare and the drug maker. It is not necessarily the price you pay at the pharmacy counter. Your actual cost depends heavily on your Part D plan's specific rules, your deductible, and whether you pay a flat copay or a percentage-based coinsurance.
The First 10 Selected Drugs with Negotiated Prices
The first phase of the Medicare negotiated drug prices program officially took effect on January 1, 2026. Medicare selected 10 specific medications that account for a massive portion of Part D spending. These drugs treat common, chronic conditions like heart disease, diabetes, and blood clots.
The discounts on these first 10 drugs are substantial, ranging from 38% to 79% below their 2023 list prices. Some of the most notable medications included in this first group are Eliquis, Jardiance, Xarelto, and Januvia.
2026 Negotiated Drugs Overview
| Selected Medication | Common Uses | Discount Range (Below 2023 List Price) | Effective Date |
|---|---|---|---|
| Eliquis | Prevention of blood clots and stroke | 38% to 79% range across all 10 drugs | January 1, 2026 |
| Jardiance | Diabetes and heart failure | 38% to 79% range across all 10 drugs | January 1, 2026 |
| Xarelto | Prevention of blood clots and stroke | 38% to 79% range across all 10 drugs | January 1, 2026 |
| Januvia | Diabetes management | 38% to 79% range across all 10 drugs | January 1, 2026 |
While this list represents a vital first step, it is only the beginning. The program is designed to expand year after year, bringing more of the most expensive medications under the umbrella of Maximum Fair Prices.
The 15 New Medications Joining the Program for 2027
The momentum for Medicare negotiated drug prices continues into 2027 and beyond. Following the initial 10 drugs in 2026, Medicare has selected 15 additional medications that will be subject to negotiated prices taking effect on January 1, 2027. This brings the total number of negotiated drugs to 25.
The expansion does not stop there. Another 15 drugs are currently in the negotiation process for the 2028 plan year. By law, the final negotiated prices for these 2028 medications must be published by November 30, 2026. This gives insurance companies time to factor the new prices into their plan designs before the next enrollment period.
Why the Phased Rollout Matters
You might wonder why Medicare doesn't just negotiate prices for all drugs at once. The phased rollout is designed to ensure stability in the Part D market. By targeting the most expensive and widely used drugs first, Medicare can deliver the largest immediate savings to the system while giving insurance companies time to adjust their formularies (their lists of covered drugs) and premium structures.
For you, this means that every year, you need to check if your specific medications have been added to the negotiated list. If they have, it could change how you shop for Part D Drug Plans during the Annual Open Enrollment Period.
Why Your Pharmacy Copay Did Not Drop Overnight
This is perhaps the most misunderstood aspect of Medicare negotiated drug prices. Many seniors expected to walk into their pharmacy on January 1, 2026, and instantly see their bills cut in half. For many, that did not happen. To understand why, we have to look at the "Copay Disconnect."
The negotiated Maximum Fair Price is the amount Medicare pays the pharmacy. It lowers the total cost of the drug. However, how much of that cost gets passed on to you depends entirely on how your Part D insurance plan charges you for your prescriptions. Plans generally charge you in one of two ways: a flat copay or coinsurance.
The Flat Copay Scenario
A flat copay is a set dollar amount you pay for a prescription, regardless of the drug's total list price. For example, your plan might say that all "Tier 3" brand-name drugs cost a $45 copay per refill.
Let's say you take Eliquis, and before 2026, the drug's list price was $500. Your plan charged you your flat $45 copay, and the insurance company paid the remaining $455. In 2026, the new negotiated price drops the total cost of Eliquis to, say, $200. Because your plan uses a flat copay, you still pay exactly $45 at the counter. The insurance company now only has to pay $155. In this scenario, the insurance company saves money, but your out-of-pocket cost does not change.
The Coinsurance Scenario
Coinsurance is a percentage of the drug's total cost. If your plan charges coinsurance, you will see immediate, direct savings from Medicare negotiated drug prices.
Imagine your plan charges a 25% coinsurance for Jardiance. Before 2026, if the list price was $600, your 25% share would be $150. In 2026, if the negotiated price drops the total cost to $300, your 25% share drops to just $75. You save money instantly because your cost is tied directly to the drug's total price.
This is why it is so critical to read your plan's Summary of Benefits. Knowing whether you pay a flat copay or coinsurance is the key to understanding if you will actually save money at the pharmacy counter.
How the 2026 and 2027 Part D Deductibles Impact Negotiated Drugs
Before your flat copays or coinsurance even kick in, you usually have to meet your annual Part D deductible. This is the amount you must pay out of your own pocket for your medications before your insurance starts sharing the cost.
The maximum standard Part D deductible is set by Medicare each year. In 2026, the maximum standard deductible is $615. In 2027, that maximum standard deductible rises to $700. Keep in mind that some plans offer a $0 deductible, but they often charge higher monthly premiums to make up for it.
Savings During the Deductible Phase
While you might not see savings if you have a flat copay, you will almost certainly see savings during your deductible phase. When you are in the deductible phase, you are responsible for paying 100% of the drug's cost.
If you take a negotiated drug like Xarelto in January while trying to meet your $615 deductible, you are now paying 100% of the new, lower negotiated price, rather than 100% of the old, inflated list price. This means your out-of-pocket cost for that first fill of the year will be significantly lower, keeping more money in your bank account during those early months.
Formulary Tiers and Maximum Fair Prices
Even with Medicare negotiated drug prices in place, insurance companies still have a lot of control over how they cover medications. Every Part D plan has a formulary, which organizes covered drugs into different "tiers." Generally, Tier 1 drugs are low-cost generics, while Tier 4 or 5 drugs are expensive specialty medications.
Just because a drug has a negotiated Maximum Fair Price does not mean an insurance company has to put it on a cheap tier. A plan might still place Januvia on a Tier 3 or Tier 4 level, meaning your copay or coinsurance could still be relatively high.
Coverage Rules Still Apply
Another common misconception is that negotiated drugs are now universally accessible without any red tape. This is false. Part D plans can still enforce strict coverage rules on these medications, including:
- Prior Authorization: Your doctor must prove to the insurance company that the drug is medically necessary before the plan will cover it.
- Step Therapy: The plan may require you to try a cheaper, alternative medication first. If the cheaper drug fails, they will then approve the negotiated drug.
- Quantity Limits: The plan may only allow you to fill a certain amount of the medication per month (for example, 30 pills for a 30-day supply).
When you review your coverage for the upcoming year, you must check not only the price of the drug but also whether any of these restrictions have been added to your formulary.
How the 2026 and 2027 Out-of-Pocket Caps Protect You
One of the most important changes to Medicare Part D is the introduction of strict annual limits on your out-of-pocket spending. In the past, the dreaded "donut hole" left seniors paying thousands of dollars with no hard limit in sight. Now, the law provides a firm safety net.
In 2026, your out-of-pocket prescription drug costs are capped at $2,100. In 2027, that cap increases slightly to $2,400. Once you spend this amount out of your own pocket on covered Part D medications, you pay $0 for your covered drugs for the rest of the calendar year.
The "Pace to the Cap" Trap
While the out-of-pocket cap is a massive relief for seniors with high drug costs, the new negotiated prices create an interesting side effect: the "Pace to the Cap" trap.
Because the total cost of negotiated drugs is now lower, less money is being spent at the pharmacy counter. If you pay coinsurance, you are paying less per month. While saving money month-to-month is great, it means you are accumulating out-of-pocket costs much slower.
For patients who rely on hitting their out-of-pocket cap early in the year (so they can get free medications for the remaining months), this lower pace means they might not reach the $2,100 or $2,400 cap until much later in the year, or perhaps not at all. You save money on the specific negotiated drug, but you might end up paying copays for your other, non-negotiated drugs for more months of the year.
Comparing the 2026 and 2027 Part D Limits
| Medicare Part D Metric | 2026 Plan Year | 2027 Plan Year |
|---|---|---|
| Maximum Standard Deductible | $615 | $700 |
| Annual Out-of-Pocket Cap | $2,100 | $2,400 |
| Base Beneficiary Premium | $38.99 | $41.33 |
| Average Stand-alone Premium | $35.09 | $36.00 (Projected) |
To learn more about what spending actually counts toward these limits, you can read our detailed guide on the Medicare Part D Out of Pocket Cap.
The Medicare Prescription Payment Plan (MPPP)
If you are worried about affording your medications early in the year while trying to meet your deductible or reach your out-of-pocket cap, there is a new option available. The Medicare Prescription Payment Plan allows you to opt into a "smoothing" program.
Instead of paying massive lump sums at the pharmacy counter in January or February, this program allows you to spread your out-of-pocket drug costs into manageable monthly payments over the entire plan year. You can learn more about whether the Medicare Prescription Payment Plan is worth it for your specific situation.
What to Check in Your Annual Notice of Change
Every September, your current Part D or Medicare Advantage plan will mail you an Annual Notice of Change (ANOC) document. This paperwork outlines exactly how your plan's costs, rules, and formulary will change for the upcoming year.
Because Medicare negotiated drug prices are constantly evolving, and new drugs are added each year, you cannot assume your coverage will stay the same. If your plan is losing money because of the new rules, they might raise your premiums or change your drug tiers to compensate.
Your ANOC Review Checklist
- Check your drug tiers: Did any of your medications move to a more expensive tier?
- Check the pricing structure: Did your plan switch from a flat copay to a coinsurance model for your specific tier?
- Check for new restrictions: Have they added Prior Authorization or Step Therapy requirements for your prescriptions?
- Check the deductible: Did your plan's deductible increase to the new $615 (2026) or $700 (2027) maximum?
- Check the premium: While the 2027 average premium is projected at $36.00 by CMS, estimates suggest it could average $51 if current enrollees do not shop around and switch plans.
How to Compare Formulary Costs on Medicare Plan Finder
If you review your ANOC and find that your costs are going up, you have the right to switch plans. The Annual Open Enrollment Period (AEP) runs from October 15 to December 7 every year. Any changes you make during this window take effect on January 1 of the following year.
If you are enrolled in a Medicare Advantage plan that includes drug coverage, you have an additional Medicare Advantage Open Enrollment period from January 1 to March 31 every year to switch to a different Advantage plan or return to Original Medicare and buy a standalone Part D plan.
Avoiding the Late Enrollment Penalty
If you are new to Medicare, you have a 7-month Initial Enrollment Period (the 3 months before your 65th birthday month, your birthday month, and the 3 months after). It is vital to enroll in creditable drug coverage during this time.
If you go 63 or more consecutive days without creditable prescription drug coverage after your initial period, you will face a permanent late enrollment penalty. The penalty is 1% of the national base beneficiary premium for every full month you were uncovered.
Because the base premium changes, the penalty changes too. A 12-month penalty in 2026 adds roughly $4.68 per month (12% of the $38.99 base premium). In 2027, that same 12-month penalty increases to roughly $4.96 per month (12% of the $41.33 base premium). This penalty lasts for as long as you have Medicare Part D.
How to Compare Medicare Part D Rates on Genie Medicare
Navigating Medicare negotiated drug prices, deductibles, and out-of-pocket caps can feel overwhelming, but finding the right plan doesn't have to be. At Genie Medicare, we make it incredibly easy to see your options.
You can compare rates for Part D Drug Plans in your ZIP code in about 30 seconds. We show you the prices first—no name, phone number, or email address is required just to look. If you decide you want to explore other coverage options, you can also easily compare Medicare Advantage rates on our site. When you are ready to enroll or if you just have a few questions, our licensed agents are standing by to provide free, friendly help to grant your Medicare rate wish.
Let Genie grant your Medicare rate wish
Compare Part D Drug Plans rates in about 30 seconds. No name, phone or email needed to see prices.
Frequently asked questions
What are the 10 Medicare negotiated drugs for 2026?
The first 10 drugs selected for negotiated prices include widely used medications like Eliquis, Jardiance, Xarelto, and Januvia. These new prices took effect on January 1, 2026, offering discounts that range from 38% to 79% below their 2023 list prices.
Will my copay go down with Medicare negotiated drug prices?
Not necessarily. If your Part D plan charges a flat dollar copay for your medication tier, your cost will likely stay the same. You will generally only see an immediate drop in your pharmacy costs if your plan charges a percentage-based coinsurance, or if you are currently paying 100% of the cost during your deductible phase.
What is the Medicare Part D out-of-pocket maximum for 2026 and 2027?
In 2026, your out-of-pocket prescription drug costs are capped at $2,100 for the year. In 2027, the out-of-pocket maximum increases slightly to $2,400. Once you spend this amount on covered medications, you pay nothing for your covered drugs for the remainder of the calendar year.
How is the Medicare Part D penalty calculated for 2026 and 2027?
The penalty is 1% of the national base beneficiary premium for every full month you went without coverage. The base premium is $38.99 in 2026 and $41.33 in 2027. For example, a 12-month penalty adds about $4.68 per month to your premium in 2026, and $4.96 per month in 2027.
When is the Medicare open enrollment period?
The Annual Open Enrollment Period (AEP) runs from October 15 to December 7 every year. During this time, you can join, switch, or drop Medicare Part D or Medicare Advantage plans. Any changes you make during this window will take effect on January 1 of the following year.
Can I spread out my Medicare drug costs?
Yes. Through the Medicare Prescription Payment Plan, you can opt into a smoothing program. Instead of paying large lump sums at the pharmacy counter early in the year, this program allows you to spread your out-of-pocket medication costs into manageable monthly payments over the entire plan year.
Sources
This article is for general information and isn't insurance, medical, legal or tax advice. Plan costs and benefits change every year and depend on where you live, your age and your health. Genie Medicare is not connected with or endorsed by the U.S. government or the federal Medicare program.